Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedSeveral key resources related to rare diseases and clinical trials have been removed, including links to specific disease pages and treatment information, which may impact access to important medical data.SummaryDifference4%
- Check41 days agoChange DetectedNew resources related to rare diseases and specific treatments, including links to Glioblastoma and Glioma information, as well as drug information for Bevacizumab and Pembrolizumab, have been added.SummaryDifference0.4%
- Check48 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.